CPRX

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a commercial-stage biopharmaceutical company founded in 2002 and headquartered in Coral Gables, Florida. The company went public in 2006 and focuses on developing and commercializing therapies for rare debilitating, chronic neuromuscular, and neurological diseases. Originally known as Catalyst Pharmaceutical Partners, Inc., the company changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Over the past two decades, Catalyst has evolved from a development-stage company to a profitable commercial enterprise with multiple marketed products generating nearly $500 million in annual revenue.